Mestinon 180 mg/1 (Pyridostigmine Bromide TABLET, EXTENDED RELEASE) 180 mg/1

Mestinon 180 mg/1 is an extended-release tablet containing pyridostigmine bromide, used to manage symptoms of myasthenia gravis. This medication helps improve muscle strength and function.

Strength

180 mg/1

Pack Size

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-3013-30)

Manufacturer / TM Owner

Bausch Health US, LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mestinon 180 mg/1 is primarily used to treat myasthenia gravis, a condition that causes weakness in the voluntary muscles. Pyridostigmine bromide works by improving nerve-to-muscle communication, which can help alleviate muscle weakness and fatigue. People often ask, 'What is Mestinon used for?' and the answer is that it is commonly prescribed for managing symptoms of myasthenia gravis.

Side Effects

Common effects of Mestinon 180 mg/1 may include increased muscle strength and improved physical endurance. Some users might experience gastrointestinal discomfort or increased salivation. These effects can vary from person to person.

Precautions & Warnings

Mestinon 180 mg/1 should be handled with care, especially if you have certain medical conditions like asthma or peptic ulcers. It is important to follow the advice of a healthcare professional regarding its use. Always store the medication in a cool, dry place away from direct sunlight.

Avoid Interactions

Mestinon 180 mg/1 may interact with certain medications, including other cholinergic drugs and some antibiotics. It is advisable to consult a healthcare provider before combining it with other treatments. Alcohol and certain foods might also affect its efficacy.

Frequently Asked Questions

Mestinon 180 mg/1 is used to manage symptoms of myasthenia gravis, a condition that causes muscle weakness.

Pyridostigmine bromide improves nerve-to-muscle communication, helping to alleviate muscle weakness and fatigue.

Common side effects may include gastrointestinal discomfort and increased salivation.

It is important to consult a healthcare provider before combining Mestinon 180 mg/1 with other medications.

Mestinon 180 mg/1 should be stored in a cool, dry place away from direct sunlight.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.